TrueVision Systems gains patent on real-time surgical guidance for astigmatism correction

Ophthalmic 3D surgical guidance and visualization technology developer TrueVision 3D Surgical (Santa Barbara, CA) has been issued a patent by the U.S. Patent & Trademark Office (USPTO) for fundamental technology underlying computer-guided methods for limbal and corneal relaxing (LRI/AK) incisions for astigmatism-correcting procedures.

Related: 'Heads-up' 3D-enabled retinal surgery broadcast live

The company's U.S. patent no. is 8,784,443 B2. It broadly discloses and claims real-time multidimensional visualizations of target surgical fields with adjustable, positionally accurate, real-time, virtual surgical reference indicia that are automatically positioned to compensate for motion during the procedure.

The Computer Guided Surgery invention by the company uses preoperative data and imaging to calculate optimal incision locations to achieve specific targeted refractive outcomes for individual patients. In addition, the guidance system has the ability to integrate with surgical microscopes and/or the rapidly growing use of cataract and corneal surgical lasers, as well as display the surgical field of view in 3D and 2D simultaneously.

This U.S. patent joins a growing portfolio of issued patents and pending patent applications that the company has in association with its pioneering work in the area of surgical visualization and computer guidance.

-----

Don't miss Strategies in Biophotonics, a conference and exhibition dedicated to development and commercialization of bio-optics and biophotonics technologies!

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Johnson & Johnson to acquire ophthalmic device maker Abbott Medical Optics for $4.33B

The acquisition will include Abbott's ophthalmic products in cataract surgery, laser refractive surgery, and consumer eye health.

Third FDA-approved study supports additional potential use of laser ablation technology

The FDA has approved an additional Investigational Device Exemption (IDE) to evaluate the NeuroBlate laser ablation system.

Contract to provide U.S. Armed Forces access to laser procedure for gum tissue regeneration

The U.S. Armed Forces will have access to a laser procedure for fully regenerating gum tissues lost to disease.

Avinger signs agreement with HealthTrust for OCT image-guided atherectomy system

HealthTrust will acquire Avinger's Pantheris OCT image-guided atherectomy system that recently received FDA approval.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS